Genetic progression in the pancreatic ducts - PubMed (original) (raw)

Review

Genetic progression in the pancreatic ducts

R H Hruban et al. Am J Pathol. 2000 Jun.

No abstract available

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Progression model for pancreatic cancer. The progression from histologically normal epithelium to low-grade PanIN to high-grade PanIN (left to right) is associated with the accumulation of specific genetic alterations. (Artwork by Jennifer L. Parsons. Adapted from Reference 19 with permission.)

References

    1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study (published erratum appears in N Engl J Med 329:672; see comments). N Engl J Med 1993, 328:1365-1371 - PubMed
    1. Boyes DA, Worth AJ, Fidler HK: The results of treatment of 4389 cases of preclinical cervical squamous carcinoma. J Obstet Gynaecol Br Commonw 1970, 77:769-780 - PubMed
    1. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471 - PubMed
    1. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O: Repeated screening for colorectal cancer with fecal occult blood test: a prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989, 24:599-606 - PubMed
    1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33 - PubMed

Publication types

MeSH terms

LinkOut - more resources